Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Market Cap	5.39B +97.2%
Revenue (ttm)	2.39B +30.3%
Net Income	504.49M +25.2%
EPS	33.74 +25.0%
Shares Out	14.93M
PE Ratio	10.70
Forward PE	n/a
Dividend	16.74 (4.64%)
Ex-Dividend Date	Nov 12, 2025

Volume	16,633
Open	351.36
Previous Close	351.36
Day's Range	350.07 - 368.00
52-Week Range	160.00 - 383.00
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 9, 2026

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally. It offers various pharmaceutical dosage forms, medical preparations, cosmetics, chemicals, extracts, veterinary medicines, and pesticides. The company is also involved in support services, including combination formulations. It exports its products to Sudan, Jordan, Yemen, Iraq, Djibouti, Somalia, South Sudan, Mali, Niger, Senegal, and Libya. The company was founded in 1962 and is headquar...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,708
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In fiscal year 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.